{"id":9911,"date":"2022-10-27T22:01:23","date_gmt":"2022-10-28T02:01:23","guid":{"rendered":"https:\/\/aafa.org\/?page_id=9911"},"modified":"2026-06-29T11:35:26","modified_gmt":"2026-06-29T15:35:26","slug":"patient-focused-drug-development-asthma","status":"publish","type":"page","link":"https:\/\/aafa.org\/asthma-allergy-research\/our-research\/patient-focused-drug-development-asthma\/","title":{"rendered":"Patient Focused Drug Development: Asthma"},"content":{"rendered":"

[et_pb_section fb_built=”1″ admin_label=”Research T-Hero Section” module_class=”hero tert” _builder_version=”4.18.0″ _module_preset=”default” background_image=”https:\/\/aafa.org\/wp-content\/uploads\/2022\/07\/AAFA-Website_Tertiary_Research.jpg” background_position=”top_right” custom_padding=”1%||1%||true|false” saved_tabs=”all” locked=”off” collapsed=”off” global_colors_info=”{}”][et_pb_row _builder_version=”4.17.4″ _module_preset=”default” background_enable_image=”off” background_size=”initial” background_position=”bottom_left” background_horizontal_offset=”0%” custom_margin=”||||false|false” custom_padding=”2%||0px||false|false” hover_enabled=”0″ locked=”off” global_colors_info=”{}” collapsed=”off” sticky_enabled=”0″][et_pb_column type=”4_4″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text admin_label=”Nav Parent Title” module_class=”tert-parent” _builder_version=”4.27.6″ _module_preset=”default” header_2_font=”|600|||||||” header_2_text_align=”left” header_2_text_color=”#FFFFFF” header_2_font_size=”32px” custom_margin=”||0px||false|false” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]<\/p>\n

Patient Focused Drug Development: Asthma<\/h2>\n

[\/et_pb_text][et_pb_code admin_label=”Breadcrumbs” module_class=”bcrumb” _builder_version=”4.17.4″ _module_preset=”default” text_orientation=”left” custom_margin=”||||false|false” custom_padding=”||||false|false” custom_css_main_element=”font-size:16px;||color: #fff;” global_colors_info=”{}”][\/et_pb_code][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ admin_label=”Main Content” _builder_version=”4.17.4″ _module_preset=”default” custom_padding=”2%||2%||true|false” global_colors_info=”{}”][et_pb_row column_structure=”2_3,1_3″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”2_3″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_post_title meta=”off” featured_image=”off” admin_label=”Page Title” module_class=”tert-content” _builder_version=”4.17.4″ _module_preset=”default” title_font=”|600|||||||” title_text_align=”left” title_text_color=”#008c99″ title_font_size=”39px” background_enable_image=”off” background_size=”contain” background_position=”center_left” module_alignment=”left” custom_margin=”||0px||false|false” custom_padding=”||||false|false” global_colors_info=”{}”][\/et_pb_post_title][et_pb_text admin_label=” Intro Content” module_class=”secondary-intro” _builder_version=”4.17.6″ _module_preset=”default” text_text_color=”#505050″ text_font_size=”24px” text_line_height=”1.5em” header_2_font=”|600|||||||” header_2_text_color=”#008c99″ header_2_font_size=”39px” custom_margin=”||3%||false|false” global_colors_info=”{}”]<\/p>\n

Treatment priorities of children living with asthma are at the core of a special initiative called \u201cLittle Airways, Big Voices.”<\/p>\n

[\/et_pb_text][et_pb_text admin_label=”Page Content” module_class=”secondary-intro” _builder_version=”4.17.6″ _module_preset=”default” text_text_color=”#505050″ text_line_height=”1.5em” header_2_font=”|600|||||||” header_2_text_color=”#008c99″ header_2_font_size=”39px” custom_margin=”||3%||false|false” custom_padding=”8px|||||” global_colors_info=”{}”]<\/p>\n

AAFA partnered with the Allergy & Asthma Network (AAN)<\/a>,\u00a0<\/span>American Lung Association (ALA),<\/a> and the <\/span>American Partnership for Eosinophilic Disorders (APFED)<\/a>, <\/span>to create an opportunity for your perspective to inform and shape development of drugs and medical devices designed to treat asthma in children.<\/p>\n

As part of the collaboration, we hosted an externally-led patient-focused drug development (PFDD) meeting on September 20, 2021 in the Washington, D.C. area. It provided the asthma community an opportunity to speak directly to Food and Drug Administration (FDA) staff, representatives of pharmaceutical and medical device companies, and other key stakeholders.<\/p>\n

The goal of the Little Airways, Big Voices PFDD meeting was to gather patient insights about living with and managing asthma in childhood<\/strong>\u00a0that will inform new treatment strategies, effectively engage families in drug development, and improve health outcomes.<\/span><\/p>\n

This initiative was the first of its kind for pediatric asthma. Your voice and perspectives are essential for us to elevate the needs of children and their families managing asthma.<\/p>\n

[\/et_pb_text][et_pb_text admin_label=”Download PDFs” _builder_version=”4.27.0″ _module_preset=”default” text_text_color=”#505050″ link_font=”||||on||||” link_text_color=”#008c99″ header_4_font=”|600|||||||” header_4_text_color=”#008c99″ background_image=”https:\/\/aafa.org\/wp-content\/uploads\/2022\/06\/small_swoosh_BG.png” background_size=”initial” background_position=”top_left” background_horizontal_offset=”0%” background_vertical_offset=”0%” global_colors_info=”{}”]<\/p>\n

Download PDFs<\/h4>\n

Little Airways Big Voices<\/a>\"Download.<\/p>\n

[\/et_pb_text][et_pb_code admin_label=”Print” module_id=”print” module_class=”clearfix” _builder_version=”4.17.6″ _module_preset=”default” global_module=”5156″ saved_tabs=”all” global_colors_info=”{}”]<\/svg> Print post<\/a> [\/et_pb_code][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.17.4″ _module_preset=”default” custom_padding=”6%||||false|false” global_colors_info=”{}”][et_pb_text ul_type=”none” disabled_on=”on|on|on” admin_label=”Side Nav – PFDD” module_class=”sidenav” _builder_version=”4.18.0″ _module_preset=”default” text_text_color=”#008C99″ text_font_size=”14px” link_text_align=”left” link_text_color=”#008C99″ link_font_size=”16px” link_line_height=”1.7em” ul_text_color=”#008C99″ ul_font_size=”16px” ul_line_height=”1.7em” header_4_font=”|700|||||||” header_4_text_align=”left” header_4_text_color=”#008C99″ header_4_font_size=”16px” header_4_line_height=”1.7em” background_color=”#F5EDDF” custom_padding=”6%|6%|6%|6%|true|true” border_color_top=”#008C99″ global_module=”10080″ saved_tabs=”all” global_colors_info=”{}” link_text_color__hover_enabled=”on|hover” link_text_color__hover=”#692D87″]<\/p>\n

Patient-Focused Drug Development<\/a><\/h4>\n